Late preterm infants: severe hyperbilirubinemia and postnatal glucose homeostasis

D H Adamkin1

  • 1Department of Pediatrics, University of Louisville School of Medicine, Louisville, KY 40202, USA. ulneomed@louisville.edu

Insights

Late preterm infants, comprising most premature births, face significant health risks like hypoglycemia and hyperbilirubinemia. Recognizing their unique needs is crucial for preventing severe morbidities and mortality.

Area of Science:

  • Neonatology
  • Pediatrics
  • Public Health

Background:

  • Late preterm infants (34-36 weeks gestation) represent a significant portion of premature births.
  • Historically, these infants were considered low-risk, leading to 'silent morbidity and mortality'.
  • Unique physiological risks in late preterm infants were previously unrecognized, leading to suboptimal care and readmissions.

Purpose of the Study:

  • To highlight the high-risk nature of late preterm infants.
  • To underscore the need for recognizing specific risks, such as neonatal hypoglycemia and severe hyperbilirubinemia.
  • To advocate for improved identification and management strategies for this vulnerable population.

Main Methods:

  • Review of existing literature and public health data on late preterm infant outcomes.
  • Analysis of common morbidities including neonatal hypoglycemia and hyperbilirubinemia.
  • Comparison of care practices in Well Baby Nurseries versus specialized neonatal care.

Main Results:

  • Late preterm infants experience significant, often unrecognized, health risks.
  • Neonatal hypoglycemia and severe hyperbilirubinemia are common and increasing problems.
  • Early discharge despite risks contributes to readmissions and severe outcomes.

Conclusions:

  • Late preterm infants require specialized attention due to their unique risks.
  • Improved diagnostic criteria and management protocols are essential.
  • Public health initiatives are needed to address the 'silent morbidity and mortality' in this group.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...